Skip to main content
All Reports

Parkinson's Research — 2026-08-25

August 25, 2026

4 sections

8 findings

Clinical Trials

  • Effect of vitamin D supplementation on clinical outcomes of patients w

    The indexed record describes research on effect of vitamin d supplementation on clinical outcomes of patients with parkinson disease: a randomized controlled study.. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov
  • Regulatory endorsement for the application of α-synuclein seed amplifi

    The indexed record describes research on regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies.. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov

Breakthrough Treatments

  • Why do some patients adhere worse? The role of frailty and depression

    The indexed record describes research on why do some patients adhere worse? the role of frailty and depression in parkinson disease. . The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov
  • Treatment of Parkinson Disease

    The indexed record describes research on treatment of parkinson disease.. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov

Lifestyle Interventions

  • Serum Norepinephrine, Chromogranin A, and Orexin A in Parkinson Diseas

    The indexed record describes research on serum norepinephrine, chromogranin a, and orexin a in parkinson disease with orthostatic hypotension: a cross-sectional study. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: europepmc.org
  • Development and validation of a nomogram prediction model for sleep di

    The indexed record describes research on development and validation of a nomogram prediction model for sleep disorders in elderly parkinson disease patients based on multidimensional data: a retrospective case-control study.. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov

Emerging Research

  • Glucocerebrosidase dysfunction in GBA1 carriers

    The indexed record describes research on glucocerebrosidase dysfunction in gba1 carriers: insights from blood and macrophage analyses.. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov
  • NERINE reveals rare variant associations in gene networks across pheno

    The indexed record describes research on nerine reveals rare variant associations in gene networks across phenotypes and implicates an snca-prl-lrrk2 subnetwork in parkinson's disease.. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov

This report is for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

All ReportsFree, updated daily